Skip to content

Clinical trials

Phase 3 Carcinoma, Non-Small-Cell Lung trials in Slovenia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 3 Country / region: Slovenia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20063
20081
20091
20112
20131
20151
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Helsinn Therapeutics (U.S.), Inc2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Amgen1
AstraZeneca1
ETOP IBCSG Partners Foundation1
GlaxoSmithKline1
Gustave Roussy, Cancer Campus, Grand Paris1
Pfizer1
Synta Pharmaceuticals Corp.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms3
Cachexia2
Adenocarcinoma of Lung1
Anemia1
Carcinoma1
Carcinoma, Large Cell1
Carcinoma, Squamous Cell1
Neoplasms1
Pancreatic Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.